Comparing MSP Recovery (NASDAQ:MSPR) and Fulgent Genetics (NASDAQ:FLGT)

Fulgent Genetics (NASDAQ:FLGT) and MSP Recovery (NASDAQ:MSPR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, dividends, earnings and risk.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Fulgent Genetics and MSP Recovery, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fulgent Genetics	1	2	2	0	2.20
MSP Recovery	1	0	0	0	1.00

Fulgent Genetics currently has a consensus price target of $32.00, indicating a potential upside of 101.26%. Given Fulgent Genetics’ stronger consensus rating and higher probable upside, equities analysts clearly believe Fulgent Genetics is more favorable than MSP Recovery.

Profitability

This table compares Fulgent Genetics and MSP Recovery’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Fulgent Genetics	-18.75%	-2.22%	-2.05%
MSP Recovery	-7,328.48%	-326.80%	-81.27%

Risk and Volatility

Fulgent Genetics has a beta of 0.94, suggesting that its stock price is 6% less volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.9, suggesting that its stock price is 390% less volatile than the S&P 500.

Earnings & Valuation

This table compares Fulgent Genetics and MSP Recovery”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fulgent Genetics	$322.67 million	1.54	-$60.51 million	($1.96)	-8.11
MSP Recovery	$9.81 million	0.05	-$360.50 million	($572.83)	0.00

Fulgent Genetics has higher revenue and earnings than MSP Recovery. Fulgent Genetics is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

48.1% of Fulgent Genetics shares are held by institutional investors. Comparatively, 3.8% of MSP Recovery shares are held by institutional investors. 33.1% of Fulgent Genetics shares are held by insiders. Comparatively, 50.5% of MSP Recovery shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Fulgent Genetics beats MSP Recovery on 12 of the 14 factors compared between the two stocks.

About Fulgent Genetics

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company’s clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

About MSP Recovery

MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.